GlassScriptPhysician profile
Traci Van Gorden
NPI 1679513451
$1,080.07
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $859 · 2022: $221.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $223.46 | 2021-2022 | |
| Amgen INC. | $183.56 | 2021-2022 | |
| Lilly USA, LLC | $91.77 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $80.77 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.18 | 2021-2022 | |
| Corcept Therapeutics | $54.15 | 2021 | |
| Amarin Pharma, INC. | $51.85 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.34 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $42.67 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.94 | 2022 | |
| Abbvie INC. | $31.39 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $30.56 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.72 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $19.57 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.70 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.41 | 2021 | |
| Eisai INC. | $12.51 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.38 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.01 | 2022 | |
| Therapeuticsmd, INC. | $11.64 | 2021 | |
| Radius Health, INC. | $11.49 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Van Gorden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.